Zambiri ― Chichewa

Urticaria nthawi zambiri imakhala ndi zoyamba zokwezeka kwambiri. Nthawi zina imachitika pamodzi ndi kutupa kwa minofu yapansi. Chithandizo chachikulu chimaphatikizapo kupewa zinthu zomwe zingayambitse, ngati zikudziwika. Mankhwala oyamba amaphatikizapo antihistamines atsopano, omwe amatha kusinthidwa kukhala apamwamba ngati akufunikira. Mankhwala ena monga antihistamines akale, H2 blockers, leukotriene receptor antagonists, antihistamines amphamvu, ndi maphunziro afupifupi a corticosteroids amatha kuwonjezeredwa ngati chithandizo chowonjezera. Ngati urticaria ikupitilira ngakhale izi zakhala zotsatira, odwala amatha kutumizidwa kwa akatswiri kuti apeze chithandizo chowonjezera monga omalizumab kapena cyclosporine.
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.

Ndemanga iyi ikuwonetsa malangizo aposachedwa ochiza urticaria ndikupereka kumvetsetsa kwatsopano zomwe zimayambitsa.
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.

Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids